We are live on ! Find out more
BIM

Baldwin Investment Management Portfolio holdings

AUM $1.03B
1-Year Est. Return 22.29%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
+22.29%
3 Year Est. Return
+74.82%
5 Year Est. Return
+112.14%
10 Year Est. Return
+391.06%
AUM
$548M
AUM Growth
+$41.8M
Cap. Flow
+$1.63M
Cap. Flow %
0.3%
Top 10 Hldgs %
51.82%
Holding
256
New
21
Increased
79
Reduced
110
Closed
14

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.29M
2
GM icon
General Motors
GM
+$1.04M
3
FISV
Fiserv Inc
FISV
+$1.04M
4
TER icon
Teradyne
TER
+$1.03M
5
CBT icon
Cabot Corp
CBT
+$982K

Sector Composition

Rank Sector Weight
1 Financials 49.48%
2 Technology 13.22%
3 Healthcare 8.84%
4 Industrials 5.98%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XEL icon
226
Xcel Energy
XEL
$47.9B
$224K 0.04%
3,375
KKR icon
227
KKR & Co
KKR
$93B
$223K 0.04%
4,567
-600
-12% -$26.8K
CSX icon
228
CSX Corp
CSX
$93B
$222K 0.04%
6,900
-300
-4% -$9.16K
IWM icon
229
iShares Russell 2000 ETF
IWM
$81.4B
$221K 0.04%
+1,000
New +$218K
ALLE icon
230
Allegion
ALLE
$14.1B
$220K 0.04%
1,750
-100
-5% -$11.5K
EEM icon
231
iShares MSCI Emerging Markets ETF
EEM
$29.8B
$220K 0.04%
4,120
+220
+6% +$12K
MO icon
232
Altria Group
MO
$111B
$217K 0.04%
+4,242
New +$190K
GSK icon
233
GSK
GSK
$104B
$214K 0.04%
4,800
-2,720
-36% -$123K
IYY icon
234
iShares Dow Jones US ETF
IYY
$3.07B
$212K 0.04%
2,120
-400
-16% -$39K
XBI icon
235
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$212K 0.04%
+1,563
New +$234K
ORCL icon
236
Oracle
ORCL
$434B
$211K 0.04%
+3,000
New +$194K
VUG icon
237
Vanguard Morningstar Growth ETF
VUG
$230B
$211K 0.04%
4,920
TFX icon
238
Teleflex
TFX
$5.95B
$208K 0.04%
500
VWO icon
239
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$203K 0.04%
3,892
-823
-17% -$43.8K
XLI icon
240
State Street Industrial Select Sector SPDR ETF
XLI
$34.5B
$202K 0.04%
+2,050
New +$188K
BDX icon
241
Becton Dickinson
BDX
$48.7B
-851
Closed -$208K
CI icon
242
Cigna
CI
$73.5B
-1,400
Closed -$291K
GII icon
243
State Street SPDR S&P Global Infrastructure ETF
GII
$929M
-4,150
Closed -$207K
KHC icon
244
Kraft Heinz
KHC
$29.4B
-7,200
Closed -$250K
NEM icon
245
Newmont
NEM
$122B
-6,215
Closed -$372K
NVS icon
246
Novartis
NVS
$297B
-2,142
Closed -$202K
PCAR icon
247
PACCAR
PCAR
$68.8B
-4,650
Closed -$267K
SCHB icon
248
Schwab US Broad Market ETF
SCHB
$44.8B
-17,958
Closed -$272K
SCHE icon
249
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
-6,600
Closed -$202K
SRPT icon
250
Sarepta Therapeutics
SRPT
$1.78B
-2,300
Closed -$392K

Similar funds

Baldwin Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Baldwin Investment Management held 256 positions worth $548M, up 8.3% from $506M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Baldwin Investment Management's Q1 2021 filing shows 21 new, 79 increased, 110 reduced and 14 closed positions. Its largest new stake was Vertex Pharmaceuticals: 5,865 shares worth $1.26M. The largest sale was Berkshire Hathaway Class A, an estimated $1.47M.

By sector, the portfolio is most concentrated in Financials at 49% of assets, up from 48% a quarter earlier, followed by Technology and Healthcare.

  • Baldwin Investment Management's largest Q1 2021 buy was Vertex Pharmaceuticals: 5,865 shares worth $1.26M.
  • Baldwin Investment Management added most to Fiserv Inc in Q1 2021, an estimated $1.04M increase.
  • Baldwin Investment Management's biggest Q1 2021 reduction was Berkshire Hathaway Class A, cutting an estimated $1.47M.
  • Baldwin Investment Management fully exited Vanguard Dividend Appreciation ETF in Q1 2021, selling an estimated $692K.
  • Baldwin Investment Management's ten largest holdings make up 52% of its $548M portfolio in Q1 2021.
  • Baldwin Investment Management opened 21 new positions and closed 14 in Q1 2021.
  • Baldwin Investment Management's portfolio value rose 8.3% quarter-over-quarter to $548M.

Based on Baldwin Investment Management's 13F filing for Q1 2021, filed 14 May 2021.